Orca Bio is preparing to make a splash in the cell therapy market. | Orca Bio is preparing to make a splash in the cell ...

Achieve Life Sciences, Inc. has announced that additional findings from its Phase 3 ORCA-3 study on cytisinicline, a treatment for nicotine dependence, will be presented at the 2025 American ...

A video posted to social media has the public and some marine scientists intrigued. It shows a killer whale in Howe Sound ...

Fisheries and Oceans Canada has confirmed that an orca swam into a fish farm near Tofino this winter, later swimming out ...

The Ripple-related token faces mounting bearish pressure amid technical breakdown and increased selling volume.

Market resilience amid geopolitical uncertainty positions XRP as a potential alternative to traditional settlement mechanisms ...

"Following the positive Phase 3 results for Orca-T, we remain focused on a 2025 BLA submission and ensuring commercial readiness. In parallel, we are advancing our pipeline of groundbreaking cell ...

Metro reinstated fare enforcement on March 31. As of May 31, the transit authority is officially cracking down on fare ...

Notably, results from the ORCA-3 study were published in JAMA Internal Medicine, presenting detailed safety and efficacy data for cytisinicline since the previous financial update. Research ...

The recently published results from the Phase 3 ORCA-3 trial in JAMA Internal Medicine support cytisinicline's efficacy and safety. The trial demonstrated positive outcomes in reducing nicotine ...